Smoking Cessation Treatment for Patients With Mental Disorders Using CBT and Combined Pharmacotherapy

References

• Anthenelli, R. M., Morris, C., Ramey, T. S., Dubrava, S. J., Tsilkos, K., Russ, C., & Yunis, C. (2013). Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: A randomized trial. Annals of Internal Medicine, 159(6), 390–400. doi:10.7326/0003-4819-159-6-201309170-00005
   PubMed Web of Science ®Google Scholar
• Aubin, H. J., Rollema, H., Svensson, T. H., & Winterer, G. (2012). Smoking, quitting, and psychiatric disease: A review. Neuroscience & Biobehavioral Reviews, 36(1), 271–284. doi:10.1016/j.neubiorev.2011.06.007
   PubMed Web of Science ®Google Scholar
• Aveyard, P., & Bauld, L. (2011). Incentives for promoting smoking cessation: What we still do not know. Cochrane Database of Systematic Reviews, 8, ED000027. doi:10.1002/14651858.ED000027
   Web of Science ®Google Scholar
• Batra, A., Friederich, H. M., & Lutz, U. (2009). Treatment of tobacco dependence: A responsibility of the psychiatry and the addiction medicine. Nervenarzt, 80, 1022–1029. doi:10.1007/s00115-009-2744-y
   PubMed Web of Science ®Google Scholar
• Cahill, K., Stevens, S., Perera, R., & Lancaster, T. (2013). Pharmacological interventions for smoking cessation: An overview of reviews. Cochrane Database of Systematic Reviews, 5, CD009329. doi:10.1002/14651858.CD009329.pub2
   PubMed Web of Science ®Google Scholar
• Castaldelli-Maia, J. M., Carvalho, C. F. C., Armentano, F., Frallonardo, F. P., Alves, T. C., Andrade, A. G., & Nicastri, S. (2013). Outcome predictors of smoking cessation treatment provided by an addiction care unit between 2007 and 2010. Revista Brasileira de Psiquiatria, 35(4), 338–346. doi:10.1590/1516-4446-2012-0907
   PubMed Web of Science ®Google Scholar
• Castaldelli-Maia, J. M., Loreto, A. R., Carvalho, C. F. C., Frallonardo, F. P., & de Andrade, A. G. (2014). Retention predictors of a smoking treatment provided by a public psychosocial unit in Brazil. International Review of Psychiatry, 26(4), 515–523. doi:10.3109/09540261.2014.928272
   PubMed Web of Science ®Google Scholar
• Castaldelli-Maia, J. M., & Ventriglio, A. (2016). The impact of Basaglia on Brazilian psychiatry. International Journal of Social Psychiatry, 62(5), 411–414. doi:10.1177/0020764016642491
   PubMed Web of Science ®Google Scholar
• Chengappa, K. R., Perkins, K. A., Brar, J. S., Schlicht, P. J., Turkin, S. R., Hetrick, M. L., … George, T. P. (2014). Varenicline for smoking cessation in bipolar disorder: A randomized, double-blind, placebo-controlled study. The Journal of Clinical Psychiatry, 75(7), 765–772. doi:10.4088/JCP.13m08756
   PubMed Web of Science ®Google Scholar
• Etter, J. F., Duc, T. V., & Perneger, T. V. (1999). Validity of the Fagerstrom Test for Nicotine Dependence and of the Heaviness of Smoking Index among relatively light smokers. Addiction, 94(2), 269–281.
   PubMed Web of Science ®Google Scholar
• Evins, A. E., Cather, C., Culhane, M. A., Birnbaum, A., Horowitz, J., Hsieh, E., … Goff, D. C. (2007). A 12-week double-blind, placebo-controlled study of bupropion SR added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. Journal of Clinical Psychopharmacology, 27(4), 380–386.
   PubMed Web of Science ®Google Scholar
• Evins, A. E., Cather, C., & Laffer, A. (2015). Treatment of tobacco use disorders in smokers with serious mental illness: Toward clinical best practices. Harvard Review of Psychiatry, 23(2), 90–98. doi:10.1097/HRP.0000000000000063
   PubMed Web of Science ®Google Scholar
• Evins, A. E., Cather, C., Pratt, S. A., Pachas, G. N., Hoeppner, S. S., Goff, D. C., … Schoenfeld, D. A. (2014). Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: A randomized clinical trial. Journal of the American Medical Association, 311(2), 145–154. doi:10.1001/jama.2013.285113
   PubMed Web of Science ®Google Scholar
• Fagerström, K., & Aubin, H. J. (2009). Management of smoking cessation in patients with psychiatric disorders. Current Medical Research and Opinion, 25(2), 511–518. doi:10.1185/03007990802707568
   PubMed Web of Science ®Google Scholar
• Green, A., Yancy, W. S., Braxton, L., & Westman, E. C. (2003). Residential smoking therapy. Journal of General Internal Medicine, 18(4), 275–280.
   PubMed Web of Science ®Google Scholar
• Hitsman, B., Moss, T. G., Montoya, I. D., & George, T. P. (2009). Treatment of tobacco dependence in mental health and addictive disorders. The Canadian Journal of Psychiatry, 54(6), 368–378.
   PubMed Web of Science ®Google Scholar
• Kozlowski, L. T., Porter, C. Q., Orleans, C. T., Pope, M. A., & Heatherton, T. (1994). Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HSI. Drug and Alcohol Dependence, 34(3), 211–216.
   PubMed Web of Science ®Google Scholar
• Lacasse, Y., Maltais, F., & Goldstein, R. S. (2002). Smoking cessation in pulmonary rehabilitation: Goal or prerequisite?. Journal of Cardiopulmonary Rehabilitation and Prevention, 22(3), 148–153.
   Google Scholar
• Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000). Smoking and mental illness: A population-based prevalence study. Journal of the American Medical Association, 284(20), 2606–2610.
   PubMed Web of Science ®Google Scholar
• Levinson, A. H., Valverde, P., Garrett, K., Kimminau, M., Burns, E. K., Albright, K., & Flynn, D. (2015). Community-based navigators for tobacco cessation treatment: A proof-of-concept pilot study among low-income smokers. BMC Public Health, 15(1), 1. doi:10.1186/s12889-015-1962-4
   PubMed Web of Science ®Google Scholar
• Meyer, C., Ulbricht, S., Haug, S., Broda, A., Bischof, G., Rumpf, H. J., & John, U. (2016). Motivating smokers to quit using computer-generated letters that target either reduction or cessation: A population-based randomized controlled trial among smokers who do not intend to quit. Drug and Alcohol Dependence, 166, 177186. doi:10.1016/j.drugalcdep.2016.07.009
   Web of Science ®Google Scholar
• Mielke, F. B., Kantorski, L. P., Jardim, V. M. D. R., Olschowsky, A., & Machado, M. S. (2009). Mental care delivered in psychosocial care centers (CAPS) from the viewpoint of the professionals. Ciência & Saúde Coletiva, 14(1), 159–164.
   PubMed Web of Science ®Google Scholar
• Miranda, L., & Campos, R. T. O. (2008). Análise do trabalho de referência em Centros de Atenção Psicossocial. Revista de Saúde Pública, 42(5), 907–913.
   PubMedGoogle Scholar
• Morisano, D., Bacher, I., Audrain-McGovern, J., & George, T. P. (2009). Mechanisms underlying the comorbidity of tobacco use in mental health and addictive disorders. The Canadian Journal of Psychiatry, 54(6), 356–367.
   PubMed Web of Science ®Google Scholar
• Ogden, J., & Hills, L. (2008). Understanding sustained behavior change: The role of life crises and the process of reinvention. Health, 12(4), 419–437. doi:10.1177/1363459308094417
   PubMed Web of Science ®Google Scholar
• Pachas, G. N., Cather, C., Pratt, S. I., Hoeppner, B., Nino, J., Carlini, S. V., … Goff, D. C. (2012). Varenicline for smoking cessation in schizophrenia: Safety and effectiveness in a 12-week open-label trial. Journal of Dual Diagnosis, 8(2), 117–125.
   PubMed Web of Science ®Google Scholar
• Perkins, K. A., & Scott, J. (2008). Sex differences in long-term smoking cessation rates due to nicotine patch. Nicotine & Tobacco Research, 10(7), 1245–1251. doi:10.1080/14622200802097506
   PubMed Web of Science ®Google Scholar
• Prochaska, J. J., Delucchi, K., & Hall, S. M. (2004). A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. Journal of Consulting and Clinical Psychology, 72(6), 1144–1156.
   PubMed Web of Science ®Google Scholar
• Raw, M., Regan, S., Rigotti, N. A., & McNeill, A. (2009). A survey of tobacco dependence treatment guidelines in 31 countries. Addiction, 104(7), 1243–1250. doi:10.1111/j.1360-0443.2009.02584.x
   PubMed Web of Science ®Google Scholar
• Roberts, E., Eden Evins, A., McNeill, A., & Robson, D. (2016). Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: A systematic review and network meta‐analysis. Addiction, 111(4), 599–612. doi:10.1111/add.13236.
   PubMed Web of Science ®Google Scholar
• Russell, P. O., Epstein, L. H., Johnston, J. J., Block, D. R., & Blair, E. (1988). The effects of physical activity as maintenance for smoking cessation. Addictive Behaviors, 13(2), 215–218.
   PubMed Web of Science ®Google Scholar
• Shiffman, S., Johnston, J. A., Khayrallah, M., Elash, C. A., Gwaltney, C. J., Paty, J. A., & DeVeaugh-Geiss, J. (2000). The effect of bupropion on nicotine craving and withdrawal. Psychopharmacology, 148(1), 33–40.
   PubMed Web of Science ®Google Scholar
• Stead, L. F., Koilpillai, P., Fanshawe, T. R., & Lancaster, T. (2016). Combined pharmacotherapy and behavioural interventions for smoking cessation. The Cochrane Database of Systematic Reviews, 3, CD008286. doi:10.1002/14651858.CD008286.pub3
   PubMed Web of Science ®Google Scholar
• Stead, L. F., Koilpillai, P., & Lancaster, T. (2015). Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation. Cochrane Database of Systematic Reviews, 10, CD009670. doi:10.1002/14651858.CD009670.pub3
   PubMed Web of Science ®Google Scholar
• Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann-Boyce, J., Cahill, K., & Lancaster, T. (2011). Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews, 11, CD000146. doi:10.1002/14651858.CD000146.pub4
   Web of Science ®Google Scholar
• Steinberg, M. B., Bover, M. T., Richardson, D. L., Schmelzer, A. C., Williams, J. M., & Foulds, J. (2011). Abstinence and psychological distress in co-morbid smokers using various pharmacotherapies. Drug and Alcohol Dependence, 114(1), 77–81. doi:10.1016/j.drugalcdep.2010.06.022
   PubMed Web of Science ®Google Scholar
• Strong, D. R., Kahler, C. W., Leventhal, A. M., Abrantes, A. M., Lloyd-Richardson, E., Niaura, R., & Brown, R. A. (2009). Impact of bupropion and cognitive–behavioral treatment for depression on positive affect, negative affect, and urges to smoke during cessation treatment. Nicotine & Tobacco Research, 11(10), 1142–1153. doi:10.1093/ntr/ntp111
   PubMed Web of Science ®Google Scholar
• Taylor, M., Leonardi‐Bee, J., Agboola, S., McNeill, A., & Coleman, T. (2011). Cost effectiveness of interventions to reduce relapse to smoking following smoking cessation. Addiction, 106(10), 1819–1826. doi:10.1111/j.1360-0443.2011.03493.x
   PubMed Web of Science ®Google Scholar
• Willemse, B. W. M., Ten Hacken, N. H. T., Rutgers, B., Lesman-Leegte, I. G. A. T., Postma, D. S., & Timens, W. (2005). Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers. European Respiratory Journal, 26(5), 835–845.
   PubMed Web of Science ®Google Scholar
• Williams, J. M., Anthenelli, R. M., Morris, C. D., Treadow, J., Thompson, J. R., Yunis, C., & George, T. P. (2012). A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder. Journal of Clinical Psychiatry, 73(5), 654–660. doi:10.4088/JCP.11m07522
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2011). WHO report on the global tobacco epidemic, 2011: Warning about the dangers of tobacco. 2011. Geneva, Switzerland: WHO.
   Google Scholar
• Ziedonis, D., Hitsman, B., Beckham, J. C., Zvolensky, M., Adler, L. E., Audrain-McGovern, J., & Calhoun, P. S. (2008). Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine & Tobacco Research, 10(12), 1691–1715. doi:10.1080/14622200802443569
   PubMed Web of Science ®Google Scholar